ebook Munafa Stock Market Course + Intraday & FNO calls  

       

NVO announcements Novo Nordisk A/s announcements and dividends declared NYSE

Novo Nordisk A/s Complete list of announcements declared & dividend announcements by Novo Nordisk A/s NVO

Novo Nordisk A/s NVO listed on NYSE and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Novo Nordisk A/s NVO

Novo Nordisk, Eli Lilly fall after Trump vows to lower weight-loss drug costs

Announcement as on 17 October 2025

Morgan Stanley slashes rating on Novo Nordisk, says Alzheimer trial will fail

Announcement as on 29 September 2025

Why Novo Nordisk Stock Slumped on Monday
Key PointsAn analyst downgraded his recommendation on the Danish pharmaceutical's equity.
Announcement as on 29 September 2025

Novo Nordisk to test weight-loss drugs in broader range of obesity-linked conditions
Novo Nordisk is broadening its focus beyond obesity and diabetes by exploring the potential of its weight-loss drugs, including Wegovy, to treat conditions like knee osteoarthritis and sleep apnea. Clinical trials are planned to investigate the impact of C
Announcement as on 16 September 2025

Novo Nordisk Wins EU Label Update For Rybelsus To Include Heart Benefits
(RTTNews) - Novo Nordisk B A/S (NVO), Monday announced that the European Medicines Agency's Committee for Medicinal Products for Human Use has approved a label update for Rybelsus to include cardiovascular benefits demonstrated in the SOUL trial.
Announcement as on 15 September 2025

Announcements by Novo Nordisk A/s first page | Next page | Prev page |

NVO Novo Nordisk A/s current price & indicator signals

Moving Averages for Novo Nordisk A/s

  • 5Day Average: 48.11
  • 12Day Average: 48.45
  • 20Day Average: 48.15
  • 50Day Average: 49.83
  • 100Day Average: 52.38
  • 150Day Average: 58.32
  • 200Day Average: 61.02

NVO Indicators & signals

Indicator MACD (12,26,9)

48.38, 48.7, -0.43
Indicator MACD is in negative zone

Indicator ADX (14)

20, 19.75, 29.63
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 53
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of NVO Novo Nordisk A/s are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
22 Mon Dec 2025 48.11 47.59 to 48.84 0% 0.63 times
19 Fri Dec 2025 48.11 46.84 to 48.80 1.03% 0.7 times
18 Thu Dec 2025 47.62 47.52 to 48.31 -0.31% 0.54 times
17 Wed Dec 2025 47.77 47.73 to 48.75 -2.43% 0.67 times
16 Tue Dec 2025 48.96 48.41 to 49.97 -2.8% 1.2 times
15 Mon Dec 2025 50.37 49.55 to 50.66 0.38% 0.96 times
12 Fri Dec 2025 50.18 49.92 to 50.75 -0.22% 1.05 times
11 Thu Dec 2025 50.29 49.59 to 50.54 2.53% 1.32 times
10 Wed Dec 2025 49.05 47.04 to 49.50 5.8% 1.44 times
09 Tue Dec 2025 46.36 46.08 to 46.79 -0.88% 0.87 times
08 Mon Dec 2025 46.77 46.35 to 47.17 -2.26% 1.25 times
05 Fri Dec 2025 47.85 47.83 to 49.15 -0.29% 0.76 times

Videos related to: NVO announcements Novo Nordisk A/s announcements and dividends declared NYSE

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

NVO announcements Novo Nordisk A/s announcements and dividends declared NYSE

 

Back to top